Envoy Medical, Inc.
COCH
$1.14
-$0.01-0.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 222.00K | 212.00K | 225.00K | 278.00K | 302.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 222.00K | 212.00K | 225.00K | 278.00K | 302.00K |
| Cost of Revenue | 804.00K | 815.00K | 742.00K | 819.00K | 821.00K |
| Gross Profit | -582.00K | -603.00K | -517.00K | -541.00K | -519.00K |
| SG&A Expenses | 8.63M | 8.29M | 8.54M | 10.13M | 9.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.90M | 19.67M | 19.46M | 21.71M | 20.15M |
| Operating Income | -19.68M | -19.46M | -19.23M | -21.43M | -19.84M |
| Income Before Tax | -21.27M | -19.52M | -20.80M | -21.07M | -13.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.27 | -19.52 | -20.80 | -21.07 | -13.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.27M | -19.52M | -20.80M | -21.07M | -13.55M |
| EBIT | -19.68M | -19.46M | -19.23M | -21.43M | -19.84M |
| EBITDA | -19.43M | -19.26M | -19.06M | -21.26M | -19.69M |
| EPS Basic | -1.46 | -1.42 | -1.54 | -1.40 | -0.90 |
| Normalized Basic EPS | -0.68 | -0.65 | -0.71 | -0.70 | -0.71 |
| EPS Diluted | -1.47 | -1.43 | -1.55 | -1.41 | -0.91 |
| Normalized Diluted EPS | -0.68 | -0.65 | -0.71 | -0.70 | -0.69 |
| Average Basic Shares Outstanding | 78.67M | 75.89M | 73.16M | 75.54M | 66.14M |
| Average Diluted Shares Outstanding | 78.67M | 75.89M | 73.16M | 75.54M | 67.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -20.06% | -18.75% | -11.77% | -8.70% | -- |